Suven secures patents for neurodegenerative disease treatments: Suven Life Sciences Ltd (Suven) announced today the grant of one product patent from Eurasia  and one from Norway, for new chemicals to treat  neurodegenerative diseases.

With these new patents, the company has a total of twenty patents from Eurasia, and six from Norway. They are aimed at treating disorders like Alzheimer’s disease, Attention deficient hyperactivity disorder (ADHD), Huntington’s disease, Major Depressive disorder (MDD), Parkinson and Schizophrenia. Pharma companies have been on a quest for next generation neuro-degenerative disease treatments, and a recent promising drug by Eli Lilly for Alzheimer’s had failed in a large trial.